A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer

BACKGROUND: We conducted a phase I/Ib, open-label, single-arm trial to assess the safety, tolerability and optimal scheduling regimen of OTSGC-A24 cancer vaccine in patients with advanced gastric cancer. METHODS: Patients with advanced gastric cancer with HLA-A*24:02 haplotype were included in this...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Sundar, Raghav, Rha, Sun Young, Yamaue, Hiroki, Katsuda, Masahiro, Kono, Koji, Kim, Hyo Song, Kim, Chan, Mimura, Kousaku, Kua, Ley-Fang, Yong, Wei Peng
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5870101/
https://ncbi.nlm.nih.gov/pubmed/29587677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4234-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars